IPO registrations (S-1, F-1) · Registrants

CATALYST PHARMACEUTICALS, INC.

SEC CIK
1369568 · filings on EDGAR ↗
Name on the registration
CATALYST PHARMACEUTICAL PARTNERS, INC.
Former names
Catalyst Pharmaceutical Partners, Inc. (2011–2015); CATALYST PHARMACEUTICAL PARTNERS, INC. (2011–2015)
Registration
Form S-1, first filed 2006-07-25, last 2012-05-04; 2 initial registrations, 7 amendments
Outcome
Final prospectus filed 2006-11-08; declared effective 2006-11-07
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
355 ALHAMBRA CIRCLE, SUITE 801, Coral Gables, FL 33134
EDGAR entity type
operating
Insiders and CEO pay
CATALYST PHARMACEUTICALS, INC. on the corporate pages

Offering terms

Final price
$1.14 per share (424B4 filed 2006-11-08, an initial public offering)
Shares sold
3,350,000
Gross proceeds
$3,819,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CPRX
Lead underwriters
Stifel (1,172,500 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 20

FiledFormWhat it isName as filedEDGAR
2006-07-25S-1S-1 (registration)Catalyst Pharmaceutical Partners, Inc.0000950144-06-006906 ↗
2006-09-01S-1/AS-1/A (amendment)Catalyst Pharmaceutical Partners, Inc.0000950144-06-008469 ↗
2006-09-26S-1/AS-1/A (amendment)Catalyst Pharmaceutical Partners, Inc.0000950144-06-009063 ↗
2006-10-04S-1/AS-1/A (amendment)Catalyst Pharmaceutical Partners, Inc.0000950144-06-009258 ↗
2006-10-18S-1/AS-1/A (amendment)Catalyst Pharmaceutical Partners, Inc.0000950144-06-009581 ↗
2006-11-07S-1/AS-1/A (amendment)Catalyst Pharmaceutical Partners, Inc.0000950144-06-010324 ↗
2006-11-07EFFECTEFFECT (declared effective)Catalyst Pharmaceutical Partners, Inc.9999999995-06-002203 ↗
2006-11-08424B4424B4 (final prospectus)Catalyst Pharmaceutical Partners, Inc.0000950144-06-010451 ↗
2008-06-26EFFECTEFFECT (declared effective)Catalyst Pharmaceutical Partners, Inc.9999999995-08-002035 ↗
2010-12-15EFFECTEFFECT (declared effective)Catalyst Pharmaceutical Partners, Inc.9999999995-10-003597 ↗
2012-04-06S-1S-1 (registration)CATALYST PHARMACEUTICAL PARTNERS, INC.0001193125-12-153699 ↗
2012-04-25S-1/AS-1/A (amendment)CATALYST PHARMACEUTICAL PARTNERS, INC.0001193125-12-179641 ↗
2012-05-04S-1/AS-1/A (amendment)CATALYST PHARMACEUTICAL PARTNERS, INC.0001193125-12-210518 ↗
2012-05-07EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-12-001442 ↗
2012-05-16EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-12-001577 ↗
2012-05-23EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-12-001630 ↗
2012-05-24424B4424B4 (final prospectus)CATALYST PHARMACEUTICAL PARTNERS, INC.0001193125-12-246194 ↗
2012-08-31EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-12-002633 ↗
2013-12-03EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-13-003419 ↗
2014-03-19EFFECTEFFECT (declared effective)CATALYST PHARMACEUTICAL PARTNERS, INC.9999999995-14-000696 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2006-11-07S-1/Aregistration statement$6.003,350,000$20,100,000Nasdaq CPRX1primary document; price sentence, shares headline, proceeds computed, cover names 1document ↗
2006-11-08424B4final prospectus$1.143,350,000$3,819,000Nasdaq CPRX1primary document; price line, shares headline, proceeds computed, underwriting table 1, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
COELHO PHILIP HDirector552006–2023
HUCKEL HUBERT E MDDirector; Director,TenPercentOwner152006–2014
MCENANY PATRICK JDirector,Officer; Director,Officer,TenPercentOwner; Director,OtherChairman and CEO; Chairman, President and CEO; President and CEO; President and Chief Executive922006–2026person page Fuzzy
O'Keeffe Charles BDirector722006–2025
Tierney David SDirector502006–2026
WALLACE MILTON JDirector182006–2012person page Fuzzy
Weinstein JackOfficerV.P., Treasurer & CFO142006–2010
Winship M DouglasOfficerV.P. of Regulatory Operations; VP, Regulatory Operations132006–2015
GRANDE ALICIAOfficerChief Accounting Officer; Chief Financial Officer; Controller & CAO; VP, Treasurer and CFO422007–2023
Miller SteveOfficerChief Operating Officer; Chief Oper./Scientific Officer; Chief Op. & Scientific Officer; VP Development & Management502007–2026
Rieger RichardOfficerVP Commercial Operations12011
BIOMARIN PHARMACEUTICAL INCTenPercentOwner22012
MUTH DAVID DOfficerEVP, Chief Commercial Officer; Exec. V.P., Corp. Development52014–2015
Daly Richard JDirector; Director,OfficerPresident and CEO332015–2026
DENKHAUS DONALD ADirector432015–2026
INGENITO GARYOfficerChief Medical Officer; Chief Medical & Reg. Officer; Chief Med. & Reg. Officer342015–2025
Merrigan Paul JOfficerChief Commercial Officer32015–2016
BRENNAN DANIELOfficerChief Commercial Officer32018–2019
Elsbernd BrianOfficerChief Compliance/Legal Officer; Chief Legal Officer292019–2026
Del Carmen JeffreyOfficerChief Commercial Officer272020–2026
Harper MollyDirector202021–2026
Sundaram PreethiOfficerChief Product Devel. Officer; Chief Strategy Officer192021–2026
Thompson TamarDirector72023–2026
Kalb Michael WayneOfficerChief Financial Officer; Executive Vice President & CFO62024–2026
Russo GreggOfficerChief HR Officer52025–2026
Andrews William T.OfficerChief Medical Officer42025–2026
Curran Daniel J.Director32025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCatalyst Pharmaceuticals, Inc.FLState business registriesname and state
Business registrationCatalyst Pharmaceuticals, Inc.FLState business registriesname and state
Business registrationCATALYST PHARMACEUTICALS, INC.FLState business registriesname and state
Business registrationCATALYST PHARMACEUTICALS, INC.FLState business registriesname and state
Business registrationCATALYST PHARMACEUTICALS, INC.FLState business registriesname and state
Business registrationCATALYST PHARMACEUTICALS, INC.FLState business registriesname and state
Plan sponsorCATALYST PHARMACEUTICALS, INC.FLForm 5500 (employee benefit plans)name and state
Federal award recipientCATALYST PHARMACEUTICALS, INCFLFederal spending (USAspending)name and state
Lobbying clientCATALYST PHARMACEUTICALSFLFederal lobbying (LDA)name and state
Lobbying clientCATALYST PHARMACEUTICALSFLFederal lobbying (LDA)name and state
Paying companyCATALYST PHARMACEUTICALS, INC.FLOpen Payments (drug and device company payments)name and state
Patent assigneeCatalyst Pharmaceuticals, Inc.FLPatents (USPTO)name and state
SEC filerCATALYST PHARMACEUTICALS, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerCatalyst Pharmaceuticals, Inc.FLTrademarks (USPTO)name and state
Person pageMilton J WallacePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pagePatrick J McenanyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Other)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, FL first:

More with this interest.

In other datasets, the same topic (Health) in FL:

Interests: Pharmaceutical Preparations · Health